Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IGKC Antikörper

Dieses Kaninchen Monoklonal-Antikörper erkennt spezifisch IGKC in WB. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7267846

Kurzübersicht für IGKC Antikörper (ABIN7267846)

Target

IGKC (Immunoglobulin kappa Constant (IGKC))

Reaktivität

Human

Wirt

  • 22
  • 10
Kaninchen

Klonalität

  • 25
  • 7
Monoklonal

Konjugat

  • 19
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IGKC Antikörper ist unkonjugiert

Applikation

  • 18
  • 10
  • 9
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
Western Blotting (WB)
  • Verwendungszweck

    Human Ig Kappa Chain Rabbit mAb

    Kreuzreaktivität

    Human, Maus, Ratte

    Produktmerkmale

    Monoclonal Antibodies

    Aufreinigung

    Affinity purification

    Immunogen

    A synthesized peptide derived from human Human Ig Kappa Chain

    Isotyp

    IgG
  • Applikationshinweise

    WB,1:1000 - 1:5000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide,0.05 % BSA,50 % glycerol, pH 7.3.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Avoid freeze / thaw cycles.
  • Target

    IGKC (Immunoglobulin kappa Constant (IGKC))

    Andere Bezeichnung

    IGKC

    Hintergrund

    Constant region of immunoglobulin light chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.,HCAK1, IGKCD, Km,Immunology & Inflammation,IGKC

    Molekulargewicht

    26kDa

    Gen-ID

    3514

    UniProt

    P01834
Sie sind hier:
Chat with us!